Healthcare · Pharmaceuticals & Biotechnology
QVM read Quality in motion Quality Strong, Valuation Expensive, Momentum Bullish
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #76 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 17 Jun 2023 | Kedarmal Shankarlal Bankda | Promoter | Buy | 0 | ₹0 |
| 17 Jun 2023 | Shankarlal Bankda HUF | Promoter group | Sell | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 30 Sep 2026 | QE SECURITIES LLP | Bulk | Sell | 5,408,128 | 25.5100 | NSE |
| 30 Sep 2026 | ALPHAGREP SECURITIES PRIVATE LIMITED | Bulk | Sell | 5,365,321 | 25.4100 | NSE |
| 30 Sep 2026 | HRTI PRIVATE LIMITED | Bulk | Sell | 5,513,184 | 25.3900 | NSE |
| 30 Sep 2026 | QE SECURITIES LLP | Bulk | Buy | 5,614,628 | 25.4000 | NSE |
| 30 Sep 2026 | ALPHAGREP SECURITIES PRIVATE LIMITED | Bulk | Buy | 5,365,321 | 25.3300 | NSE |
| 30 Sep 2026 | HRTI PRIVATE LIMITED | Bulk | Buy | 4,981,329 | 25.3000 | NSE |
| 29 Sep 2026 | HRTI PRIVATE LIMITED | Bulk | Buy | 4,593,156 | 24.7000 | NSE |
| 29 Sep 2026 | MICROCURVES TRADING PRIVATE LIMITED | Bulk | Buy | 7,584,944 | 24.9400 | NSE |
| 29 Sep 2026 | JUNOMONETA FINSOL PRIVATE LIMITED | Bulk | Buy | 11,784,120 | 24.8400 | NSE |
| 29 Sep 2026 | IMC INDIA SECURITIES PRIVATE LIMITED | Bulk | Buy | 5,140,343 | 24.8600 | NSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| — | Final Dividend - Rs. - 0.1000 | — | — |
| 23 Sep 2026 | Dividend - Re 0.10 Per Share | 0.1000 | 23 Sep 2026 |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| 23 Sep 2024 | OTHER | Annual General Meeting |
| 18 Sep 2023 | OTHER | Annual General Meeting |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 11 Aug 2026 | Financial Results/Dividend/Other business matters | Yes |
| 22 May 2026 | Financial Results/Other business matters | Yes |
| 12 Feb 2026 | Financial Results/Other business matters | Yes |
| 12 Nov 2025 | Financial Results/Other business matters | Yes |
| 8 Aug 2025 | Financial Results/Other business matters | Yes |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 1 Oct 2026 | AGM/EGM | Syncom Formulations India Ltd-$ - 524470 - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| 1 Oct 2026 | AGM/EGM | Syncom Formulations India Ltd-$ - 524470 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| 1 Oct 2026 | AGM/EGM | Syncom Formulations India Ltd-$ - 524470 - Declaration Of Voting Results |
| 1 Oct 2026 | Company Update | Syncom Formulations India Ltd-$ - 524470 - Announcement under Regulation 30 (LODR)-Change in Management |
| 1 Oct 2026 | General Updates | Syncom Formulations (India) Limited has informed the Exchange about General Updates |
| 1 Oct 2026 | Change in Management | Syncom Formulations (India) Limited has informed the Exchange about change in Management |
| 1 Oct 2026 | General Updates | Syncom Formulations (India) Limited has informed the Exchange about General Updates |
| 1 Oct 2026 | Shareholders meeting | Syncom Formulations (India) Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results. |
| 1 Oct 2026 | Shareholders meeting | Syncom Formulations (India) Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026 |
| 30 Sep 2026 | AGM/EGM | Syncom Formulations India Ltd-$ - 524470 - Proceedings Of The 38Thannual General Meeting |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
